Lepore, Domenico <br/><br/>
Functional and Morphologic Findings at Four Years After Intravitreal Bevacizumab or Laser for Type 1 ROP.  [electronic resource] 

 -  Ophthalmic surgery, lasers & imaging retina  03 2020 
 - 180-186 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2325-8179 
<br/><br/><label>Standard No.: </label>10.3928/23258160-20200228-07  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Bevacizumab--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Gestational Age<br/>Humans<br/>Infant, Newborn<br/>Intravitreal Injections<br/>Laser Coagulation--methods<br/>Male<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Retina--pathology<br/>Retinopathy of Prematurity--diagnosis<br/>Retrospective Studies<br/>Time Factors<br/>Tomography, Optical Coherence--methods<br/>Treatment Outcome